Study Finds MicroRNA Signatures for Blood-Based Lung Cancer Test

A study published earlier this spring by OSU researchers identified a set of miRNA signatures in blood that could yield a new test for lung cancer development and prognosis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.